BioSpace News Archive

TB12, the performance lifestyle brand co-founded by six-time Super Bowl champion Tom Brady and business partner Alex Guerrero, today announces Tara McRae as the company’s Chief Marketing Officer.

Clinical Leader Shares How to Leverage Agility® Software Solution to Monitor the Health of Patients and Medical Staff

Blue Shield of California is offering a new digital tool to its network hospitals at no additional cost to help them triage the influx of patients seeking advice on coronavirus (COVID-19) or other medical care.

Zocdoc and PlushCare Offering Virtual Doctors’ Visits to Support Patients Amid COVID-19

SciBite announced being named the fastest-growing company identified in this year’s Alantra Pharma Fast 50, an annual ranking of privately-owned pharmaceutical businesses in the UK based on growth speed.

Oncology experts GRYT Health and AAPM launch suite of tools to connect patients to resources

Crescita Therapeutics Inc. (TSX: CTX OTC) (US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today reported its financial results for the fourth quarter (“Q4-F2019") and fiscal year ended December 31, 2019 (“F2019").

Biohaven Pharmaceutical Holding announced today that the Company’s received fast track designation from FDA

Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter of 2020. The dividend will be paid on the closing date of AbbVie’s pending acquisition of Allergan, which remains subject to regulatory approval and customary closing conditions, or on June

Onconova Therapeutics, Inc. today announced that the Company will release its year-end 2019 financial results on Tuesday, March 24, 2020, after the market closes. Management will host a conference call and live webcast at 4:30 p.m. ET on the same day to discuss these resu